ARTICLES RECENTS / RECENT PUBLICATIONS
Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction & memory deficits in Alzheimer’s disease - 2020 Nature Neuroscience
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor Brain
Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. Brain
The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? Acta Neuropathol Commun
Recent and future Seminars
Eléonore Maury (UCLouvain) Molecular basis of Circadian Desynchrony in cardiometabolic and neurodegenerative diseases. November 6, 2019 - 3:30pm
Nicole Déglon (Lausanne, CH) Genetic engineering to the rescue of Huntington's disease. October 14, 2019 - 10:30am
Delphine Boche (Southampton, UK) Microglia: the key cells for tau pathology. September 27, 2019 - 2:00pm
Frederic Checler (Valbonne, France) Presenilins-PINK1 functional interplay governs mitophagic response. September 13, 2019 - 11:00am
Diane P Hanger (London, UK) The damaging effects of truncated tau in cell and animal models of human tauopathy. July 1, 2019 - 2:30pm
Detlef Balschun (Leuven, Belgium) The synapse as pathological hotspot in neurodegeneration - an electro-physiological approach. March 22, 2019 - 11:00am
Rodrigo Cunha (Coimbra, Portugal) Role of adenosine A2A receptor in the control of mood. February 1, 2019 - 11:00am.
Franck Martin (Strasbourg) The molecular basis of the ribosome code. January 29, 2019 - 2:00pm.
Diana F Lazaro (Göttingen, Sweden) Deciphering the role of synphilin-1 on Parkinson's disease. October 31, 2018 - 2:00pm
Eric Boué-Grabot (Bordeaux) Implication of P2X receptors in synaptic plasticity and memory. September 24, 2018 - 3:00pm
Gabor Petzold (Bonn Germany) Role of astrocyte purinergic signaling in Alzheimer’s disease. September 5, 2018 - 3:00pm
Fabien Delahaye (AECOM, NY) From Discovery to Cellular Mechanism: Functional Genomics 2.0. September 3, 2018 - 11:00am
Cécile Delarasse (Paris) New role of P2X7 receptor in Alzheimer's disease. July 23, 2018 - 11:00am
EUROTAU2018. Lille, France. April 26-27, 2018.
Christian Hackenberger (Berlin, Germany) The power of chemo-selectivity – Functional antibody conjugates for intra- and extracellular targeting. March 2, 2018 - 11:00 am
Michael Heneka (Bonn, Germany) Immunity in Alzheimer's disease. February 16, 2018 - 11:00 am
Kunie Ando (Bruxelles) The role of PICALM in Tau pathology progression. February 6, 2018 - 2:00 pm.
Alain Cappy (IEMN, Villeneuve d'Ascq) Energy efficient artificial neural circuits. December 21, 2017 - 11:00 am
Thierry Galli (CPN, Paris) Conventional and unconventional secretory mechanisms in neuronal development. November 21, 2017 - 11:30 am
Giovanni Stevanin (ICM, Paris). Apport de la nouvelle génération de séquençage dans les dégénérescences cérébelleuses. October 20, 2017 - 11:00 am
Taxiarchis Katsinelos (Heidelberg, Germany) Unconventional secretion mediates the trans-cellular spreading of tau. September 28, 2017 - 3:00 pm
Tiago F Outeiro (Göttingen, Germany) Thinking beyond the nigra: alpha-synuclein mediated synaptic functions in the hippocampus. September 22, 2017 - 10:00 am.
Pietro Fazzari (Madrid, Spain) NRG1-schizophrenia risk gene: excitatory inhibitory balance in cortical circuits. September 21, 2017. 10:00 am.
Jens Brüning (Köln, Germany) CNS pathways in control of glucose metabolism. July 20, 2017 - 3:00 pm
Khalid Iqbal (IBR, Staten Island, USA) Prenatal to early postnatal treatment of Down syndrome and Alzheimer disease in animal models. July 11, 2017 - 12:30 pm
Silvia Bolognin (Luxembourg) The potential role of Rho-GTPases in the aetiology of Alzheimer’s Disease. July 11, 2017 - 11:00 am
Flavio Giorgini (University of Leicester, UK) "The kynurenine pathway and neurodegeneration: from mechanisms to therapeutics". July 7, 2017 - 11:00 am
L. de Lecea (Stanford University, USA) "To sleep or not to sleep: how the brain decides between vigilance states" June 30, 2017 - 11:00 am
Khalid Iqbal (IBR, Staten Island, USA) "Tau immunization and neuroregeneration: attempting treatment from both ends" June 29, 2017 - 2:00 pm
Maud Gratuze (Quebec, Canada) Impact of type 2 diabetes and obesity on phosphorylation of the tau protein in db/db and ob/ob mouse models: role of hypothermia. June 9, 2017 - 11:00 am
Luisa Lopes (Lisbon, Portugal) Caffeine analogs in age related memory deficits - insights from animal models. June 8, 2017 - 2:30 pm
Anne-Laurence Boutillier (Strasbourg) Epigenetic correction of defective plasticity in a mouse model of Tauopathy with an acetyltransferase activator, June 7, 2017 - 11:30 am
Florent Laferrière (Zürich, CH) Caractérisation des agrégats pathologiques de TDP-43 dans l'ALS et les FTD. June 2, 2017 - 2:00 pm
Sergi FERRE (Baltimore, NIH, USA) Allosterism within GPCR oligomers: back to symmetry. April 6, 2017 - 11:00 am
Martin DENZEL (Köln, Germany) Hexosamine pathway activation improves protein homeostasis and extends lifespan. March 17, 2017 - 3:00 pm
Jérémy TERRIEN (Brunoy, F) The grey mouse lemur. February 23, 2017
Didier VIEAU (Lille, F) L'environnement périnatal joue-t-il un rôle dans la maladie d'Alzheimer. October 14, 2016 - 1:30 pm
Sandrine HUMBERT (GIN, Grenoble) Huntingtin regulates cortical development: consequences for Huntington’s disease. October 4, 2016 - 2:00 pm
Raphaëlle PARDOSSI (IPMC, France) C99 and AICD involvement in Alzheimer's disease. Sept 20, 2016 - 4:00 pm
Thierry GALLI (Institut J Monod & CPN, Paris) Membrane trafficking and neuronal differentiation. Sept 19, 2016 - 11:00 am
Yijuang CHERN (Taipei Medical Univ.) A central role of TRAX in the ATM-mediated DNA repair during elevated oxidative stress. July 13, 2016 - 2:00 pm
Frank YATES (SupBioTech) Organoïdes neuroectodermiques: des mini-cerveaux pour modéliser les maladies neurodégénératives? July 7, 2016 - 3:00 pm
Christophe MAGNAN (Univ Paris Diderot) Rôle de la détection centrale des lipides dans le contrôle nerveux de la dépense énergétique. May 9, 2016 - 2:00 pm
Luc BUEE (Univ. Lille, F) Les maladies neurodégénératives sont-elles contagieuses? April 29, 2016, 1:00 pm
Patricia MELNYK (Univ. Lille, F) AZP2006, un candidat médicament pour la maladie d'Alzheimer. April 1, 2016, 1:00 pm
David BLUM (Univ. Lille, F) Caffeine is not a drug, it's a vitamin. March 18, 2016, 1:00 pm
Sophie HALLIEZ (Jacques Monod Institute - CNRS, Paris) The Prion Protein in all its forms. March 14, 2016 - 2:00 pm
Sébastien SART (CNRS, Ecole Polytechnique, Palaiseau) Regulation and Monitoring of Cellular Functions in 3D Spheroids. February 23, 2016 - 2:00 pm
Frank Lafont, Gabriele Kaminski (Cambridge, UK), Sylvain Gabriele (Mons, Be), Jerome Clasadonte, Vincent Thomy, Fabien Alibart, Morvane Colin. New technologies and Neurosciences: Electrophysiology, High resolution microscopy, Light-sheet microscopy, Mem-resistors, Microfluidics...: November 16, 2015
Hélène TRAN (University of Massachusetts Medical School, USA) RNA versus Protein Mediated Toxicity of C9ORF72 Repeat Expansion: Insights from a Drosophila Model. September 30, 2015
Catherine MARQUER (Columbia University Medical Center, New York City, USA) Novel role for the small GTPase Arf6 in the control of retromer trafficking, a key player in neurodegenerative diseases. September 24, 2015 - 2:00 pm
Yijuang CHERN (Taipei, Taiwan) AMPK and metabolic dysfunction in amyotrophic lateral sclerosis. June 9, 2015 - 11:00 am
McCULLOUGH L Farmington CT USA. BEZARD E, Bordeaux F; THOMASON M, Detroit MI USA; ANTHONY D, Oxford UK; BRAININ M, Krems Austria; KALARIA R Newcastle UK. DN2M meeting. "Cognitive disorders : from neuron to society" June 5-6, 2015, Lille, France
Kim TIEU (Plymouth, UK) Targeting mitochondrial dynamics as a potential therapeutic treatment for Parkinson's disease and other neurodegenerative disorders. April 10, 2015 - 11:00 am
Gerd MULTHAUP (Montreal, Canada) Aß42 oligomer interacting peptides neutralize toxic Aß42 species and suppresse fibril formation. March 16, 2015 - 11:00 am
Claudia MARINANGELI (Lille, France) Role of presenilin transmembrane domain interactions in gamma-secretase activity and characterization of natural inhibitors. Feb. 24, 2015 - 2:00 pm
Giuseppe GANGAROSSA (Paris, France) The dopaminoceptive brain: from cell-type specific events to behavior. Feb. 17, 2015 - 2:00 pm
Claire RAMPON (Toulouse, France) Maladie d'Alzheimer et neurogenèse hippocampique: A la croisée des chemins. Feb. 6, 2015 - 11:00am
Hubert HONDERMARCK (Callaghan, Australia) Nerve-Cancer Cell Crosstalk: a Novel Promoter of Tumor Progression. Jan. 20, 2015
John STEELE (Guam, US) Progressive supranuclear palsy. October 13, 2014 - 5:00pm
Dominique WEIL (Paris) P-bodies in mRNA storage and degradation. October 10, 2014 - 10:00am
Selina WRAY (London, UK) Stem cell models of frontotemporal dementia. June 16, 2014 - 11:00am
Tiago OUTEIRO (Göttingen G) From the baker to the bedside: unraveling the molecular basis of Parkinson's disease. April 7, 2014
Khalid IQBAL (Staten Island NYC) “Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer disease”. March 24, 2014 - 10:30 am
Frédéric CHECLER (Valbonne, F) Parkin transcriptional targets and neurodegenerative disorders. March 18, 2014 - 11:00am
Florence CLAVAGUERA (Basel Switzerland) Transmission and spreading of Tauopathy in transgenic mice. December 16, 2013 - 4:15pm
Sébastien HEBERT (QC Canada) micro-RNAs and dementia - version 2.0. October 17, 2013 - 10:00am
ALSO FOLLOW US ON FACEBOOK https://www.facebook.com/groups/AlzTau/
"Cras elementum ultrices diam."
A service on your city
Alzheimer & Tauopathies - Luc Buée
Copyright 2020